|
|
Stem Cell-Engineered Tumor Immunity in Man
|
5P01CA132681-02
|
$2,904,341
|
$2,526,777
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Texas Center for Cancer Nanomedicine
|
5U54CA151668-02
|
$2,579,927
|
$1,083,569
|
Gorenstein, David
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,572,000
|
$128,599
|
Wayne, Alan
|
CCR (NCI)
|
|
|
Center for Translational Cancer Nanomedicine
|
5U54CA151881-02
|
$2,558,928
|
$460,607
|
TORCHILIN, VLADIMIR
|
NORTHEASTERN UNIVERSITY
|
|
|
Carolina Center of Cancer Nanotechnology Excellence
|
5U54CA151652-02
|
$2,508,693
|
$275,956
|
DeSimone, Joseph
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-02
|
$2,446,327
|
$636,045
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
IMPROVING CORD BLOOD TRANSPLANTATION
|
1P01CA148600-01A1
|
$2,426,373
|
$606,593
|
SHPALL, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
THE THERAPY OF AML
|
5P01CA055164-19
|
$2,401,083
|
$312,141
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
MIT-Harvard Center of Cancer Nanotechnology Excellence
|
5U54CA151884-02
|
$2,290,029
|
$389,305
|
LANGER, ROBERT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
|
Studies of Childhood Solid Tumors
|
5P01CA023099-33
|
$2,230,285
|
$66,909
|
Hendershot, Linda
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
SPORE In Prostate Cancer
|
5P50CA058236-17
|
$2,185,002
|
$437,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-06A1
|
$2,185,000
|
$546,250
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Seattle Cancer Consortium Breast SPORE
|
5P50CA138293-02
|
$2,185,000
|
$174,800
|
PORTER, PEGGY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Pacific Ovarian Cancer Research Consortium
|
5P50CA083636-13
|
$2,185,000
|
$546,250
|
Urban, Nicole
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
SPORE in Prostate Cancer
|
5P50CA090386-08
|
$2,185,000
|
$152,950
|
LEE, CHUNG
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-07
|
$2,185,000
|
$131,100
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-09
|
$2,185,000
|
$174,800
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
M.D. Anderson Gynecologic SPORE for Uterine Cancers
|
5P50CA098258-07
|
$2,185,000
|
$87,400
|
Lu, Karen
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
University of Texas SPORE in Lung Cancer
|
5P50CA070907-14
|
$2,185,000
|
$437,000
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
|
Lentiviral-MGMT gene transfer into hematopoietic stem cells
|
5R42CA128269-02
|
$2,150,576
|
$2,150,576
|
GERSON, STANTON
|
LENTIGEN CORPORATION
|
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-10
|
$2,140,227
|
$107,011
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-12
|
$2,117,925
|
$254,151
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
TCR Gene Modified T Cells for Adoptive Immunotherapy
|
1P01CA154778-01A1
|
$2,032,647
|
$2,032,647
|
NISHIMURA, MICHAEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
|
MOTILITY AND INVASION
|
5P01CA100324-09
|
$2,023,001
|
$202,300
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-09
|
$1,924,347
|
$962,174
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-03
|
$1,902,504
|
$1,902,504
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
SPORE In Prostate Cancer
|
2P50CA092629-11
|
$1,901,414
|
$209,156
|
SCHER, HOWARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-11
|
$1,765,050
|
$317,709
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
|
JHU ICMIC Program
|
2P50CA103175-06A2
|
$1,619,134
|
$323,827
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
|
MSKCC Center for Molecular Imaging in Cancer
|
2P50CA086438-11
|
$1,580,501
|
$410,930
|
LARSON, STEVEN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Center for Molecular Imaging Research at MGH/HMS
|
2P50CA086355-12
|
$1,521,775
|
$60,871
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Molecular Basis of Viral and Cellular Transformation
|
5P01CA016038-38
|
$1,519,349
|
$151,935
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-12
|
$1,487,860
|
$178,543
|
Herschman, Harvey
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Engineered HSV For Treatment of Malignant Glioma
|
5P01CA071933-13
|
$1,318,625
|
$1,318,625
|
Whitley, Richard
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,298,263
|
$519,305
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,298,263
|
$519,305
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,173,211
|
$293,302
|
Court, Donald
|
CCR (NCI)
|
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-09
|
$1,127,363
|
$372,030
|
HANNUN, YUSUF
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Cell Production Facility Core
|
ZIC BC 011020
|
$885,718
|
$442,859
|
Dudley, Mark
|
CCR (NCI)
|
|
|
Cell Prep Core
|
ZIC BC 010905
|
$885,718
|
$442,859
|
Wunderlich, John
|
CCR (NCI)
|
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
5U01CA084294-13
|
$873,915
|
$87,392
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Programming and Reprogramming Human Cells
|
5R01CA084198-12
|
$852,794
|
$255,838
|
JAENISCH, RUDOLF
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
|
Molecular Pathology of Pulmonary Carcinogenesis
|
ZIA SC 000167
|
$829,908
|
$82,990
|
Linnoila, Ilona
|
CCR (NCI)
|
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$822,907
|
$123,436
|
Aladjem, Mirit
|
CCR (NCI)
|
|
|
Training Program in Molecular Oncology and Immunology
|
2T32CA009161-36A1
|
$778,188
|
$77,819
|
Levy, David
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
3P01CA081534-11S2
|
$750,000
|
$150,000
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Mouse Models for Human Cancer
|
5U01CA084301-13
|
$743,227
|
$185,807
|
KUCHERLAPATI, RAJU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-14
|
$739,271
|
$81,320
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
|
1P20CA151129-01A1
|
$700,000
|
$175,000
|
GILLESPIE, G
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Nanoparticles and Nanocapsules for Glioma Targeting
|
2R44CA135906-02
|
$666,667
|
$166,667
|
Spretz, Ruben
|
LNKCHEMSOLUTIONS
|
|
Total relevant funding to Gene Therapy for this search: $67,165,721
|
